{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:03:45Z","timestamp":1789387425144,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.mcna.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T14:22:47Z","timestamp":1425046967000},"page":"479-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Oral Contraception"],"prefix":"10.1016","volume":"99","author":[{"given":"Ginger","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza L.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mcna.2015.01.004_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0039-128X(92)90015-2","article-title":"Steroids and \u201cthe pill\u201d: early steroid research at Searle","volume":"57","author":"Colton","year":"1992","journal-title":"Steroids"},{"issue":"5548","key":"10.1016\/j.mcna.2015.01.004_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.2.5548.355","article-title":"Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee","volume":"2","year":"1967","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2105\/AJPH.59.3.418","article-title":"Oral contraceptives and mortality trends from thromboembolism in the United States","volume":"59","author":"Markush","year":"1969","journal-title":"Am J Public Health Nations Health"},{"issue":"5703","key":"10.1016\/j.mcna.2015.01.004_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010813.pub2","article-title":"Combined oral contraceptives: venous thrombosis","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2015.01.004_bib6","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use, 4th\u00a0edition. 2010. Available at: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241563888_eng.pdf?ua=1. Accessed September 21, 2014."},{"key":"10.1016\/j.mcna.2015.01.004_bib7","unstructured":"United States medical eligibility criteria (US MEC) for contraceptive use, 2010. Centers for Disease Control and Prevention Web site. Available at: http:\/\/www.cdc.gov\/reproductivehealth\/unintendedpregnancy\/usmec.htm. Accessed January 20, 2014."},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2015.01.004_bib9","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1016\/S0010-7824(98)00135-8","article-title":"Oral contraceptive health benefits: perception versus reality","volume":"59","author":"Kaunitz","year":"1999","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib10","first-page":"112","article-title":"Oral contraceptive risk assessment: a survey of 247 educated women","volume":"82","author":"Peipert","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1049-3867(97)00079-0","article-title":"Perceptions of contraceptive effectiveness and health effects of oral contraception","volume":"7","author":"Tessler","year":"1997","journal-title":"Womens Health Issues"},{"issue":"7","key":"10.1016\/j.mcna.2015.01.004_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub5","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib13","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.mcna.2015.01.004_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000341823","article-title":"Combined oral contraceptives in polycystic ovary syndrome - indications and cautions","volume":"40","author":"Bozdag","year":"2013","journal-title":"Front Horm Res"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002120.pub2","article-title":"Oral contraceptive pill as treatment for primary dysmenorrhoea","author":"Wong","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib17","first-page":"341","article-title":"Diagnosis and initial management of dysmenorrhea","volume":"89","author":"Osayande","year":"2014","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.fertnstert.2011.02.045","article-title":"Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial","volume":"95","author":"Harada","year":"2011","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"ACOG practice bulletin No. 108: polycystic ovary syndrome","volume":"114","author":"ACOG Committee on Practice Bulletins\u2013Gynecology","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG practice bulletin No. 110: noncontraceptive uses of hormonal contraceptives","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0010-7824(92)90095-B","article-title":"The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status","volume":"46","author":"Larsson","year":"1992","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.mcna.2015.01.004_bib24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006586.pub4","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001396.pub3","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006134.pub5","article-title":"Oral contraceptives for functional ovarian cysts","author":"Grimes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.mcna.2015.01.004_bib28","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sder.2008.06.002","article-title":"Hormonal therapy for acne","volume":"27","author":"George","year":"2008","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clindermatol.2009.03.006","article-title":"Hormonal therapy for acne: why not as first line therapy? Facts and controversies","volume":"28","author":"Katsambas","year":"2010","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod"},{"issue":"6586","key":"10.1016\/j.mcna.2015.01.004_bib32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bmj.294.6586.1518","article-title":"Ovarian neoplasms, functional ovarian cysts, and oral contraceptives","volume":"294","author":"Vessey","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9378(92)91371-G","article-title":"Oral contraceptive type and functional ovarian cysts","volume":"166","author":"Lanes","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2015.01.004_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10072-014-1743-3","article-title":"Menstrual migraine: treatment options","volume":"35","author":"Newman","year":"2014","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/WCO.0000000000000091","article-title":"Migraine and estrogen","volume":"27","author":"Chai","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval","volume":"47","author":"Sulak","year":"2007","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/01443615.2013.800851","article-title":"Effects of a combined oral contraceptive containing oestradiol valerate\/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study","volume":"33","author":"Mac\u00ecas","year":"2013","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.mcna.2015.01.004_bib38","unstructured":"Faculty of Sexual and Reproductive Healthcare. UK medical eligibility criteria for contraceptive use (UKMEC 2009). Royal College of Obstetricians and Gynaecologists. Available at: http:\/\/www.fsrh.org\/pdfs\/UKMEC2009.pdf. Accessed September 20, 2014. November 2009 (revised May 2010)."},{"issue":"26","key":"10.1016\/j.mcna.2015.01.004_bib39","first-page":"878","article-title":"Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-4","key":"10.1016\/j.mcna.2015.01.004_bib40","first-page":"1","article-title":"U\u00a0S. medical eligibility criteria for contraceptive use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib41","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1097\/00012272-200701000-00016","article-title":"Attitudes toward oral contraceptive use among women of reproductive age: a systematic review","volume":"30","author":"Lee","year":"2007","journal-title":"ANS Adv Nurs Sci"},{"issue":"7","key":"10.1016\/j.mcna.2015.01.004_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/jwh.2012.3955","article-title":"Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States","volume":"22","author":"Yu","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib43","doi-asserted-by":"crossref","first-page":"e93792","DOI":"10.1371\/journal.pone.0093792","article-title":"Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France","volume":"9","author":"Tricotel","year":"2014","journal-title":"PLoS One"},{"issue":"212","key":"10.1016\/j.mcna.2015.01.004_bib44","first-page":"1","article-title":"Oral contraceptive use for the primary prevention of ovarian cancer","author":"Havrilesky","year":"2013","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","article-title":"Oral contraceptives and breast cancer risk overall and by molecular subtype among young women","volume":"23","author":"Beaber","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10549-013-2823-4","article-title":"Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers","volume":"143","author":"Kotsopoulos","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","article-title":"Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study","volume":"88","author":"Vessey","year":"2013","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2007.03.015","article-title":"Oral contraception and the risk of hepatocellular carcinoma","volume":"47","author":"Maheshwari","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.2010.222109","article-title":"Changing trends in malignant transformation of hepatocellular adenoma","volume":"60","author":"Farges","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2217\/whe.09.88","article-title":"Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease","volume":"6","author":"Pugh","year":"2010","journal-title":"Womens Health (Lond Engl)"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5414\/CPP44113","article-title":"Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol","volume":"44","author":"van Giersbergen","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"20","key":"10.1016\/j.mcna.2015.01.004_bib52","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"issue":"7293","key":"10.1016\/j.mcna.2015.01.004_bib53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.322.7293.1024","article-title":"Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study","volume":"322","author":"Cosmi","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2015.01.004_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-9560-3-8","article-title":"Comparison of incidence\/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study","volume":"3","author":"Spannagl","year":"2005","journal-title":"Thromb J"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib55","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2015.01.004_bib56","unstructured":"Venous thromboembolism and hormonal contraception (green-top guideline No. 40). Royal College of Obstetricians and Gynaecologists. London. Available at: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/gtg40venousthromboembolism0910.pdf. Accessed September 19, 2014. Published September 27, 2010."},{"key":"10.1016\/j.mcna.2015.01.004_bib57","series-title":"Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing","author":"National Clinical Guideline Centre (UK)","year":"2012"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1160\/TH13-01-0011","article-title":"Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups","volume":"110","author":"De Stefano","year":"2013","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haematol"},{"issue":"RR-05","key":"10.1016\/j.mcna.2015.01.004_bib60","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition","volume":"62","author":"Division of Reproductive Health","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.contraception.2012.08.009","article-title":"Laboratory screening prior to initiating contraception: a systematic review","volume":"87","author":"Tepper","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.mcna.2015.01.004_bib62","unstructured":"Planned Parenthood. Available at: http:\/\/www.plannedparenthood.org\/get-care\/online\/video-visit. Accessed September 19, 2014."},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archinte.166.3.332","article-title":"The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions","volume":"166","author":"Shrank","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2 Pt 1","key":"10.1016\/j.mcna.2015.01.004_bib64","first-page":"447","article-title":"ACOG committee opinion No. 375: brand versus generic oral contraceptives","volume":"110","author":"Committee on Gynecologic Practice American College of Obstetricians and Gynecologists","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib65","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1517\/17425255.2012.680886","article-title":"An update on the ability of St. John's wort to affect the metabolism of other drugs","volume":"8","author":"Rahimi","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1067\/mcp.2002.121217","article-title":"Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers","volume":"71","author":"Robertson","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mcna.2015.01.004_bib67","doi-asserted-by":"crossref","first-page":"890160","DOI":"10.1155\/2012\/890160","article-title":"Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy","volume":"2012","author":"Robinson","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: a myth debunked","volume":"46","author":"Archer","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.mcna.2015.01.004_bib69","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0029-7844(01)01532-0","article-title":"Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.mcna.2015.01.004_bib70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pds.3267","article-title":"Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study","volume":"21","author":"Koopmans","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib71","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.contraception.2010.10.007","article-title":"Controversies in family planning: are all oral contraceptive formulations created equal?","volume":"83","author":"Sober","year":"2011","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.mcna.2015.01.004_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009038","article-title":"Triphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jfprhc-2013-100600","article-title":"Evolution of extended use of the combined oral contraceptive pill","volume":"40","author":"Panicker","year":"2014","journal-title":"J\u00a0Fam Plann Reprod Health Care"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2015.01.004_bib74","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0010-7824(98)00131-0","article-title":"Introduction of the pill and its impact","volume":"59","author":"Tyrer","year":"1999","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.contraception.2007.06.004","article-title":"To bleed or not to bleed, that is the question","volume":"76","author":"Coutinho","year":"2007","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(99)00043-8","article-title":"Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use","volume":"59","author":"den Tonkelaar","year":"1999","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib77","first-page":"905","article-title":"Evaluation of extended and continuous use oral contraceptives","volume":"4","author":"Wright","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.whi.2004.08.005","article-title":"Evidence about extending the duration of oral contraceptive use to suppress menstruation","volume":"14","author":"Hitchcock","year":"2004","journal-title":"Womens Health Issues"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib79","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.contraception.2004.05.006","article-title":"Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use","volume":"70","author":"Baerwald","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ogc.2007.01.001","article-title":"Extended cycle combined hormonal contraception","volume":"34","author":"Steinauer","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004695.pub2","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"5 Pt 1","key":"10.1016\/j.mcna.2015.01.004_bib82","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0029-7844(01)01555-1","article-title":"Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial","volume":"98","author":"Miller","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2005.06.068","article-title":"The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days","volume":"73","author":"Foidart","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib84","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2007.05.012","article-title":"Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive","volume":"89","author":"Davis","year":"2008","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib85","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.fertnstert.2009.01.003","article-title":"Return to fertility following discontinuation of oral contraceptives","volume":"91","author":"Barnhart","year":"2009","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib86","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.contraception.2012.09.010","article-title":"When can a woman start combined hormonal contraceptives (CHCs)? A systematic review","volume":"87","author":"Brahmi","year":"2013","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.mcna.2015.01.004_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006260.pub3","article-title":"Immediate start of hormonal contraceptives for contraception","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.mcna.2015.01.004_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub5","article-title":"20 \u03bcg versus\u00a0>20 \u03bcg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003987.pub5","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e31823d4167","article-title":"Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial","volume":"119","author":"Casta\u00f1o","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.mcna.2015.01.004_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004317.pub4","article-title":"Strategies to improve adherence and acceptability of hormonal methods of contraception","author":"Halpern","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2015.01.004_bib92","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1097\/01.AOG.0000447252.46443.3c","article-title":"A\u00a0systematic review of smartphone oral contraceptive reminder applications","volume":"123","author":"Gal","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib93","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.contraception.2012.08.004","article-title":"How does the number of oral contraceptive pill packs dispensed or prescribed affect continuation and other measures of consistent and correct use? A systematic review","volume":"87","author":"Steenland","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib94","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003552.pub4","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2015.01.004_bib96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6874-13-38","article-title":"Evaluation of factors associated with noncompliance in users of combined hormonal contraceptive methods: a cross-sectional study: results from the MIA study","volume":"13","author":"Mart\u00ednez-Astorquiza-Ortiz de Zarate","year":"2013","journal-title":"BMC Womens Health"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib97","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.contraception.2012.08.035","article-title":"Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review","volume":"87","author":"Zapata","year":"2013","journal-title":"Contraception"},{"issue":"136","key":"10.1016\/j.mcna.2015.01.004_bib98","first-page":"1","article-title":"Pregnancy rates for U.S. women continue to drop","author":"Curtin","year":"2013","journal-title":"NCHS Data Brief"},{"issue":"55","key":"10.1016\/j.mcna.2015.01.004_bib99","first-page":"1","article-title":"Intended and unintended births in the United States: 1982-2010","author":"Mosher","year":"2012","journal-title":"Natl Health Stat Report"},{"issue":"17","key":"10.1016\/j.mcna.2015.01.004_bib100","first-page":"297","article-title":"Sexual experience and contraceptive use among female teens - United States, 1995, 2002, and 2006-2010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"10.1016\/j.mcna.2015.01.004_bib101","first-page":"1","article-title":"Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth","author":"Martinez","year":"2011","journal-title":"Vital Health Stat 23"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jadohealth.2013.04.011","article-title":"Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010","volume":"53","author":"Whitaker","year":"2013","journal-title":"J\u00a0Adolesc Health"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib103","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e3182723b7d","article-title":"Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices","volume":"120","author":"Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group The American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib104","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1542\/peds.2007-2535","article-title":"Contraception and adolescents","volume":"120","author":"American Academy of Pediatrics Committee on Adolescence","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jadohealth.2006.11.143","article-title":"Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world","volume":"40","author":"Kirby","year":"2007","journal-title":"J\u00a0Adolesc Health"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib106","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bpobgyn.2014.05.007","article-title":"Postabortal and postpartum contraception","volume":"28","author":"Cameron","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"7410","key":"10.1016\/j.mcna.2015.01.004_bib107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.327.7410.313","article-title":"Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study","volume":"327","author":"Smith","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.mcna.2015.01.004_bib108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2014.04.013","article-title":"Postpartum contraception: optimizing interpregnancy intervals","volume":"89","author":"Teal","year":"2014","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.07.059","article-title":"Contraceptive counseling and postpartum contraceptive use","volume":"212","author":"Zapata","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.mcna.2015.01.004_bib110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib111","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib112","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0010-7824(87)90084-9","article-title":"ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk","volume":"35","author":"Shikary","year":"1987","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2008.04.005","article-title":"The postpartum visit: it's time for a change in order to optimally initiate contraception","volume":"78","author":"Speroff","year":"2008","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.mcna.2015.01.004_bib114","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0010-7824(86)90054-5","article-title":"Long-term follow-up of children breast-fed by mothers using oral contraceptives","volume":"34","author":"Nilsson","year":"1986","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.mcna.2015.01.004_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0378-5122(95)00985-X","article-title":"The normal menopause transition: an overview","volume":"23","author":"McKinlay","year":"1996","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib116","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/713605136","article-title":"Executive summary: Stages of Reproductive Aging Workshop (STRAW)","volume":"4","author":"Soules","year":"2001","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jwh.2013.4544","article-title":"Contraception and hormonal management in the perimenopause","volume":"24","author":"Long","year":"2015","journal-title":"J\u00a0Womens Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib118","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.fertnstert.2006.01.045","article-title":"The length of perimenopausal menstrual cycles increases later and to a greater degree than previously reported","volume":"86","author":"Ferrell","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.mcna.2015.01.004_bib119","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2013.07.009","article-title":"Contraception during the perimenopause","volume":"76","author":"Baldwin","year":"2013","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.mcna.2015.01.004_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00324720701804207","article-title":"A\u00a0new estimate of permanent sterility by age: sterility defined as the inability to conceive","volume":"62","author":"Leridon","year":"2008","journal-title":"Popul Stud (Camb)"},{"issue":"11","key":"10.1016\/j.mcna.2015.01.004_bib121","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00006254-198611000-00024","article-title":"Older maternal age and pregnancy outcome: a review of the literature","volume":"41","author":"Hansen","year":"1986","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"10.1016\/j.mcna.2015.01.004_bib122","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.AOG.0000140682.63746.be","article-title":"Advanced maternal age and adverse perinatal outcome","volume":"104","author":"Jacobsson","year":"2004","journal-title":"Obstet Gynecol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251500019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251500019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T10:16:31Z","timestamp":1566382591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571251500019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S002571251500019X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2015.01.004","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Contraception","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}